2-42644131-C-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001330442.2(MTA3):c.386C>A(p.Thr129Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000631 in 1,586,024 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330442.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000865 AC: 2AN: 231132Hom.: 0 AF XY: 0.0000159 AC XY: 2AN XY: 125802
GnomAD4 exome AF: 0.00000418 AC: 6AN: 1433938Hom.: 0 Cov.: 28 AF XY: 0.00000560 AC XY: 4AN XY: 713934
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74262
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.386C>A (p.T129N) alteration is located in exon 6 (coding exon 6) of the MTA3 gene. This alteration results from a C to A substitution at nucleotide position 386, causing the threonine (T) at amino acid position 129 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at